NCT Number: NCT00510523
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in participants with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.
Looking for future studies?
Notify MeKey information
Conditions
Age range
25 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Logan University, College of Chiropractic, Chesterfield, Missouri, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)
Exclusion criteria
- Visual or vestibular condition that would affect balance
- Non-Ms related systemic illness that would have an adverse effect on balance
- Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes
- Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates
- Acute thrombosis
- Severe migraine, epilepsy
- Serious cardiovascular disease, wearing a pacemaker
- Any Spinal manipulation within 48 hours
- Acute disc herniation, discopathy or spondylolysis
- Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance
- Any implanted device or prosthesis or intrauterine IUD type of device
- Pregnancy
Treatment and study plan
Primary outcomes
-
NeuroCom Balance Master
-
SF-EMG Nerve conduction velocity test
-
Berg balance score
Sponsors and collaborators
Lead sponsor
Logan College of Chiropractic
Other
Registry information
Important dates
- Study start
- 2006
- Study completion
- 2007
- First posted
- Aug 2, 2007
- Registry last updated
- May 3, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis
NCT03963375
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
St Louis, Missouri, United States
View Trial DetailsIn Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
NCT02511028
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bethesda, Maryland, United States
View Trial DetailsAccuracy of Motor Performance Perception in Multiple Sclerosis
NCT07175792
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Diepenbeek, Belgium
View Trial DetailsEffects of CTAR and PNF Exercises on Swallowing in Multiple Sclerosis
NCT07726667
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Gaziantep, Gaz, Turkey (Türkiye)
View Trial Details